The Turkish Health Minister, Recep Akdağ, stated Monday that Turkey will produce the first-ever vaccine against Crimean-Congo haemorrhagic fever (CCHF).
Speaking during a visit to the central Anatolian city of Kayseri, Akdağ said that Turkish Health Ministry is developing the vaccine in coordination with Kayseri's Erciyes University.
"Turkish scientists have been working day and night to develop the vaccine. We as the ministry have provided the necessary support to them. The vaccine has been studied, and Turkey is now able to produce the first-ever vaccine against the disease," he said.
"We will produce an original vaccine, not a licensed one belonging to a pharmaceutical company. We need a little more time until the research is completely carried out and the vaccine is released," Akdağ added.
Crimean-Congo haemorrhagic fever (CCHF) is a widespread disease caused by a tick-borne virus (Nairovirus) of the Bunyaviridae family. The CCHF virus causes severe viral haemorrhagic fever outbreaks, with a fatality rate of 10–40 percent in cases.
CCHF is widespread across Africa, the Balkans, the Middle East and Asian countries south of the 50th parallel north – the geographical limit of the principal tick vector.
Please click to read our informative text prepared pursuant to the Law on the Protection of Personal Data No. 6698 and to get information about the cookies used on our website in accordance with the relevant legislation.
6698 sayılı Kişisel Verilerin Korunması Kanunu uyarınca hazırlanmış aydınlatma metnimizi okumak ve sitemizde ilgili mevzuata uygun olarak kullanılan çerezlerle ilgili bilgi almak için lütfen tıklayınız.